|
Sign In to gain access to subscriptions and/or personal tools.
|
Modulation of Lipid Rafts by -3 Fatty Acids in Inflammation and Cancer: Implications for Use of Lipids During Nutrition Support
Rafat A. Siddiqui, PhD*
Kevin A. Harvey, BS*
Gary P. Zaloga, MD
William Stillwell, PhD
* Methodist Research Institute, Clarian Health
Partners, Indianapolis, Indiana; Baxter Health
Care, Deerfield, Illinois; and Departments of
Medicine and Biology, Indiana University–Purdue University,
Indianapolis, Indiana
Correspondence: Correspondence: Rafat A. Siddiqui, PhD, Methodist Research Institute, Cellular
Biochemistry, E504D, 1800 N. Capitol Ave., Indianapolis, IN 46202. Electronic
mail may be sent to
rsiddiqu{at}clarian.org.
Current understanding of biologic membrane structure and function is
largely based on the concept of lipid rafts. Lipid rafts are composed
primarily of tightly packed, liquid-ordered
sphingolipids/cholesterol/saturated phospholipids that float in a sea of more
unsaturated and loosely packed, liquid-disordered lipids. Lipid rafts have
important clinical implications because many important membrane-signaling
proteins are located within the raft regions of the membrane, and alterations
in raft structure can alter activity of these signaling proteins. Because
rafts are lipid-based, their composition, structure, and function are
susceptible to manipulation by dietary components such as -3
polyunsaturated fatty acids and by cholesterol depletion. We review how
alteration of raft lipids affects the raft/nonraft localization and hence the
function of several proteins involved in cell signaling. We focus our
discussion of raft-signaling proteins on inflammation and cancer.
Nutrition in Clinical Practice, Vol. 22, No. 1,
74-88 (2007)
DOI: 10.1177/011542650702200174

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
D. L. Waitzberg and R. S. Torrinhas
Fish Oil Lipid Emulsions and Immune Response: What Clinicians Need to Know
Nutr Clin Pract,
August 1, 2009;
24(4):
487 - 499.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. D. Altenburg and R. A. Siddiqui
Omega-3 Polyunsaturated Fatty Acids Down-Modulate CXCR4 Expression and Function in MDA-MB-231 Breast Cancer Cells
Mol. Cancer Res.,
July 1, 2009;
7(7):
1013 - 1020.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Kim, Y.-Y. Fan, R. Barhoumi, R. Smith, D. N. McMurray, and R. S. Chapkin
n-3 Polyunsaturated Fatty Acids Suppress the Localization and Activation of Signaling Proteins at the Immunological Synapse in Murine CD4+ T Cells by Affecting Lipid Raft Formation
J. Immunol.,
November 1, 2008;
181(9):
6236 - 6243.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. P. Atshaves, A. L. McIntosh, H. R. Payne, A. M. Gallegos, K. Landrock, N. Maeda, A. B. Kier, and F. Schroeder
SCP-2/SCP-x gene ablation alters lipid raft domains in primary cultured mouse hepatocytes
J. Lipid Res.,
October 1, 2007;
48(10):
2193 - 2211.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|